Search results
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 5 days ago“Our goal is to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD and, just as important, a sense of hope ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
FOX21 Colorado Springs· 5 days agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 3 days agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
For treating retinopathy of prematurity, research proves that ranibizumab is safe
Medical Xpress· 6 hours agoThe study, published in eClinicalMedicine, answers a longstanding concern about which is the safest,...
Red flag sign in your eye of silent killer that causes 75,000 UK deaths a year
Daily Express· 2 days agoHigh blood pressure - or hypertension - is a medical condition that is thought to affect around a...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results By Investing.com
Investing.com· 3 days agoIn a recent earnings call, Lineage Cell Therapeutics (NYSE:LCTX), a biotechnology company...
Clearside Biomedical stock target cut, maintains Buy rating By Investing.com
Investing.com· 10 hours agoOn Monday, Clearside Biomedical (NASDAQ:CLSD) saw its price target adjusted by H.C. Wainwright. The...
Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1
Proactive Investors· 6 days agoDrawing from his background in ophthalmology at Johns Hopkins, O'Donnell explained that the drug is...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 3 days agoIts flagship product, ADVM-022 (Ixo-vec), aims to revolutionize care for patients with wet age-related macular degeneration (AMD) by reducing the frequency ...
StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)
ETF DAILY NEWS· 20 hours agoStockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biopharmaceutical company ...